NUTEX Investments Public Limited Company

Ft 11.00As of Sun 8 Nov 2026, 12:00 UTC
BUD:NUTEXHealthcare
Country Hungary
PE (Fwd) •••
TSR 10Y CAGR (16.12%)
Div yield 90.91%
ROE 15.89%
Pharmaceutical Preparations
Beta (5Y) 1.01
PE TTM 1.877
TSR TTM (35.29%)
Mkt cap Ft 1.883B
ROIC (0.71%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
Ft 13
20.33%
(96.48%)
Hold 6|8|1|7|12
4Q25
1Q26
2Q26
3Q26
Earnings per shareFt
0.24
0.24
0.24
0.26
5.56%
10.55%
2.15%
5.30%
RevenueFt M
146.7
146.3
150.8
149.0
3.93%
2.71%
3.11%
2.82%
Peers (US$5.781M)
Cap (US$)
PE
5.961M
3.176x
5.881M
—
Capital
TTM
5Y
10Y
Leveragex
0.326
0.500
0.540
EBIT/Intx
1.385
0.195
0.183
Own earn%
(120.40)
14.87
11.60
Sh yield%
30.23
28.39
29.32
Owners
Insiders/Inst%
14.56
25.11
Short interest%
5.43
SBC / revenue%
4.53
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
8–13
$1 testx
—
Incr. ROIC%
0